BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19822483)

  • 1. Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
    Ito T; Hashizume H; Takigawa M
    Eur J Dermatol; 2010; 20(1):126-7. PubMed ID: 19822483
    [No Abstract]   [Full Text] [Related]  

  • 2. Renbök phenomenon in a patient with alopecia areata universalis and psoriasis.
    Oiso N; Kawada A
    J Dermatol; 2012 Mar; 39(3):288-9. PubMed ID: 22150402
    [No Abstract]   [Full Text] [Related]  

  • 3. Renbok phenomenon and contact sensitization in a patient with alopecia universalis.
    Harris JE; Seykora JT; Lee RA
    Arch Dermatol; 2010 Apr; 146(4):422-5. PubMed ID: 20404233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual association between scalp psoriasis and ophiasic alopecia areata: the Renbök phenomenon.
    Criado PR; Valente NY; Michalany NS; Martins JE; Romiti R; Aoki V; Vasconcellos C
    Clin Exp Dermatol; 2007 May; 32(3):320-1. PubMed ID: 17263782
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of alopecia areata in children.
    Mukherjee N; Burkhart CN; Morrell DS
    Pediatr Ann; 2009 Jul; 38(7):388-95. PubMed ID: 19685659
    [No Abstract]   [Full Text] [Related]  

  • 6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
    Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
    J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
    [No Abstract]   [Full Text] [Related]  

  • 8. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renbök phenomenon in a patient with alopecia areata universalis.
    Garnacho-Saucedo GM; Salido-Vallejo R; Alvarez-López MÁ; Casas de la Asunción E; Ruano-Ruiz J; García-Nieto AV; Jiménez-Puya R; Moreno-Giménez JC
    Arch Dermatol; 2012 Aug; 148(8):964-5. PubMed ID: 22911207
    [No Abstract]   [Full Text] [Related]  

  • 10. Hair regrowth following TNF-α blockade in coexisting psoriasis vulgaris and alopecia areata.
    Ono S; Miyachi Y; Arakawa A
    Eur J Dermatol; 2013; 23(4):537. PubMed ID: 24047580
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
    Tosti A; Guidetti MS; Bardazzi F; Misciali C
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic alopecia.
    George SM; Taylor MR; Farrant PB
    Clin Exp Dermatol; 2015 Oct; 40(7):717-21. PubMed ID: 26202646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renbok phenomenon between psoriasis and alopecia areata.
    Wylie GR; Burden D
    Clin Exp Dermatol; 2011 Oct; 36(7):816-7. PubMed ID: 21623882
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
    Bröcker EB; John SM; Steinhausen D; Hamm H
    Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
    [No Abstract]   [Full Text] [Related]  

  • 15. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Shapiro J
    Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata universalis sparing nevus flammeus.
    Chen W
    Dermatology; 2005; 210(3):227-8. PubMed ID: 15785052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia universalis in a patient with psoriasis vulgaris.
    Yamamoto T; Watanabe K; Katayama I; Nishioka K
    J Dermatol; 1995 Aug; 22(8):623-4. PubMed ID: 7560464
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.